Avindra Nath

Active 1987–2025

228
Papers
32,991
Citations
105
h-index
220
i10-index

Citations

Citations per year for Avindra Nath1988: 2 citations1989: 1 citations1990: 1 citations1991: 3 citations1992: 3 citations1993: 4 citations1994: 11 citations1995: 8 citations1996: 12 citations1997: 36 citations1998: 81 citations1999: 91 citations2000: 132 citations2001: 165 citations2002: 154 citations2003: 209 citations2004: 170 citations2005: 317 citations2006: 217 citations2007: 131 citations2008: 248 citations2009: 238 citations2010: 205 citations2011: 194 citations2012: 226 citations2013: 212 citations2014: 190 citations2015: 166 citations2016: 206 citations2017: 252 citations2018: 235 citations2019: 849 citations2020: 991 citations2021: 1,102 citations2022: 986 citations2023: 905 citations2024: 1,176 citations2025: 583 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,701 citing papers, 33.9% of this breakdownUnited Kingdom: 724 citing papers, 6.6% of this breakdownChina: 656 citing papers, 6% of this breakdownGermany: 583 citing papers, 5.4% of this breakdownItaly: 569 citing papers, 5.2% of this breakdownCanada: 417 citing papers, 3.8% of this breakdownFrance: 337 citing papers, 3.1% of this breakdownAustralia: 294 citing papers, 2.7% of this breakdownSpain: 258 citing papers, 2.4% of this breakdownNetherlands: 246 citing papers, 2.3% of this breakdownSwitzerland: 232 citing papers, 2.1% of this breakdownIndia: 196 citing papers, 1.8% of this breakdown
0%33.9%Other 24.7%

Fields

  • Medicine58.8%
  • Immunology and Microbiology17.3%
  • Biochemistry, Genetics and Molecular Biology10.3%
  • Neuroscience8.2%
  • Agricultural and Biological Sciences3.3%
  • Environmental Science0.3%
  • Other1.8%

Topics

  • HIV Research and Treatment5.6%
  • CAR-T cell therapy research5.2%
  • Neuroinflammation and Neurodegeneration Mechanisms4.7%
  • Long-Term Effects of COVID-194.7%
  • Multiple Sclerosis Research Studies2.4%
  • Amyotrophic Lateral Sclerosis Research2.2%
  • Other75.2%

Coauthors

All papers

Open in search
  1. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pietro Fratta, Gregory A. Cox, Leslie M. Thompson, Steven Finkbeiner, Efthimios Dardiotis, Timothy M. Miller, Siddharthan Chandran, Suvankar Pal, Eran Hornstein, Daniel J. MacGowan, Terry Heiman‐Patterson, Molly Hammell, Nikolaos A. Patsopoulos, Oleg Butovsky, Josh Dubnau, Avindra Nath, Robert Bowser, Matthew B. Harms, Eleonora Aronica, Mary Poss, Jennifer E. Phillips‐Cremins, John F. Crary, Nazem Atassi, Dale J. Lange, Darius J. Adams, Leonidas Stefanis, Marc Gotkine, Robert H. Baloh, Suma Babu, Towfique Raj, Sabrina Paganoni, Ophir Shalem, Colin Smith, Bin Zhang, Brent T. Harris, Iris Broce, Vivian E. Drory, John Ravits, Corey T. McMillan, Vilas Menon, Lani F. Wu, Steven J. Altschuler, Yossef Lerner, Rita Sattler, Kendall Van Keuren‐Jensen, Orit Rozenblatt–Rosen, Kerstin Lindblad‐Toh, Katharine Nicholson, Peter K. Gregersen, Jeong‐Ho Lee, Sulev Kõks, Stephen Muljo, Jia Newcombe, Emil K. Gustavsson, Sahba Seddighi, Joel F. Reyes, Steven L. Coon, Daniel M. Ramos, Giampietro Schiavo, Elizabeth Fisher, Towfique Raj, Maria Secrier, Tammaryn Lashley, Jernej Ule, Emanuele Buratti, Jack Humphrey, Michael E. Ward, Pietro Fratta - Nature 2022 cited by 514

  2. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura Tabacof, Jenna Tosto‐Mancuso, Erica Breyman, Amy Kontorovich, Dayna McCarthy, Martha Quezado, Hannes Vogel, Marco M. Hefti, Daniel P. Perl, Shane A. Liddelow, Rebecca D. Folkerth, David Putrino, Avindra Nath, Akiko Iwasaki, Michelle Monje - Cell 2022 cited by 526

  3. Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 1,609

  4. Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven A. Rosenberg - Journal of Immunotherapy 2013 cited by 1,145

  5. Amyotrophic lateral sclerosis: translating genetic discoveries into therapies

    Authors: , , , , , , - Nature Reviews Genetics 2023 cited by 212

  6. Nervous system consequences of COVID-19

    Authors: , - Science 2022 cited by 456

  7. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eran Hornstein, Daniel J. MacGowan, Terry Heiman‐Patterson, Molly Hammell, Nikolaos A. Patsopoulos, Oleg Butovsky, Josh Dubnau, Avindra Nath, Robert Bowser, Matt Harms, Eleonora Aronica, Mary Poss, Jennifer E. Phillips‐Cremins, John F. Crary, Nazem Atassi, Dale J. Lange, Darius J. Adams, Leonidas Stefanis, Marc Gotkine, Robert W. Baloh, Suma Babu, Towfique Raj, Sabrina Paganoni, Ophir Shalem, Colin Smith, Bin Zhang, Brent T. Harris, Delphine Fagegaltier, Brent T. Harris, Lyle W. Ostrow, Hemali Phatnani, John Ravits, Josh Dubnau, Molly Hammell - Cell Reports 2019 cited by 333

  8. Microvascular Injury in the Brains of Patients with Covid-19

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 602

  9. Neurovascular injury with complement activation and inflammation in COVID-19

    Authors: , , , , , , , , , , , , , - Brain 2022 cited by 243

  10. Human endogenous retrovirus-K contributes to motor neuron disease

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 493

  11. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sean C. Horan, Silvina G. Horovitz, Kory R. Johnson, Anita Jones Govan, Kristine M. Knutson, Joy D. Kreskow, Mark Levin, Jonathan J. Lyons, Nicholas Madian, Nasir Malik, Andrew L. Mammen, John A. McCulloch, Patrick McGurrin, Joshua D. Milner, Ruin Moaddel, Geoffrey A. Mueller, Amrita Mukherjee, Sandra Muñoz-Braceras, Gina Norato, Katherine Pak, Iago Pinal‐Fernandez, Traian Popa, Lauren Reoma, Michael N. Sack, Farinaz Safavi, Leorey N. Saligan, Brian A. Sellers, Stephen Sinclair, Bryan Smith, Joseph Snow, Stacey Solin, Barbara Stussman, Giorgio Trinchieri, Sara A. Turner, C. Stephenie Vetter, Felipe Vial, Carlotta Vizioli, Ashley Williams, Shanna Yang, Avindra Nath - Nature Communications 2024 cited by 125

  12. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

    Authors: , , - Nature Reviews Neurology 2020 cited by 377

  13. Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2020 cited by 191

  14. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID.

    Authors: , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2022 cited by 172

  15. Human Endogenous Retroviruses in Neurological Diseases

    Authors: , , , , , , , , - Trends in Molecular Medicine 2018 cited by 293

  16. Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Authors: , , , , , , - Frontiers in Neurology 2020 cited by 169

  17. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis

    Authors: , , , - Annals of Neurology 2010 cited by 324

  18. Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial

    Authors: , , , , , , , , , , , , , , , , - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019 cited by 101

  19. Human endogenous retrovirus-K (HML-2): a comprehensive review

    Authors: , , , - Critical Reviews in Microbiology 2018 cited by 223

  20. PML diagnostic criteria

    Authors: , , , , , , , , - Neurology 2013 cited by 695

  21. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 359

  22. CD8+ T cells target cerebrovasculature in children with cerebral malaria

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 142

  23. Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection

    Authors: , , , , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2023 cited by 54

  24. Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy

    Authors: , , , , , , , , , , , , , , - AIDS 2019 cited by 136